Article
Appropriate Dose of Ranibizumab for ROP: A Retrospective
2021-07-21
Abstract excerpt
<h4>Objective: </h4> To compare the recurrence rate of retinopathy of prematurity (ROP) after treatment with 0.3 mg vs. 0.25 mg ranibizumab. Subjects: All patients with ROP who underwent intravitreal injection of ranibizumab in Hainan General Hospital between January 2014 and May 2020 were included in this study. <h4>Methods:</h4> 82 cases (146 eyes) who received intravitreal injection of 0.25 mg ranibizumab were...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2f487182-89a9-5b8a-a9b4-49356ea0f3d8
- DOI
- 10.21203/rs.3.rs-677291/v1
